T2磁共振法监测抗真菌治疗后念珠菌血症清除的疗效:STAMP试验
STAMP多中心临床试验比较T2MR与血培养监测抗真菌治疗期间念珠菌血症清除的表现。31例完成试验,41.9%患者至少一次监测阳性;所有阳性血培养均伴T2MR阳性且菌种一致,而仅30.4%的T2MR阳性伴血培养阳性;T2MR监测显著优于血培养(P=0.004)。
要点
- T2MR监测念珠菌清除显著优于血培养(P=0.004)。
- 所有阳性血培养均伴T2MR阳性且菌种一致。
- T2MR阳性仅30.4%伴血培养阳性,提示更高检出。
核心结论
- T2MR在监测接受抗真菌治疗患者的念珠菌血症清除方面显著优于血培养。
研究设计与样本
- 多中心临床试验纳入血培养酵母阳性的成人,按预设天数行血培养和T2MR检测,31例完成试验。
主要发现
- 所有阳性血培养(7/7,100%)均伴T2MR阳性且菌种一致。
- 仅7/23(30.4%)T2MR阳性结果伴血培养阳性。
- 基于log rank检验,T2MR监测较血培养显著改善(P=0.004)。
临床怎么用
- T2MR可能有助于判断感染源控制、降阶梯时机和 optimal 疗程。
局限性
- 样本量小且缺乏结局数据。
- 需进一步研究确定T2MR检出念珠菌细胞的活力并与患者结局关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The performance of blood culture for monitoring candidemia clearance is hampered by its low sensitivity, especially during antifungal therapy. The T2 magnetic resonance (T2MR) assay combines magnetic resonance with nanotechnology to identify whole Candida species cells. A multicenter clinical trial studied the performance of T2MR in monitoring candidemia clearance compared to blood culture. Adults with a blood culture positive for yeast were enrolled and had blood cultures and T2MR testing performed on prespecified days. Thirty-one patients completed the trial. Thirteen of the 31 patients (41.9%) had at least one positive surveillance T2MR and/or blood culture result. All positive blood cultures (7/7 [100%]) had an accompanying positive T2MR result with concordance in the identified Candida sp., while only 7/23 (30.4%) T2MR results had an accompanying positive blood culture. There was one case of discordance in species identification between T2MR and the preenrollment blood culture with evidence to support deep-seated infection by the Candida spp. detected by the T2MR assay. Based on the log rank test, there was a statistically significant improvement in posttreatment surveillance using the T2MR assay compared to blood culture (P = 0.004). Limitations of the study include the small sample size and lack of outcome data. In conclusion, the T2MR assay significantly outperformed blood cultures for monitoring the clearance of candidemia in patients receiving antifungal therapy and may be useful in determining adequate source control, timing for deescalation, and optimal duration of treatment. However, further studies are needed to determine the viability of Candida species cells detected by the T2MR assay and correlate the results with patient outcomes. (This study is registered at ClinicalTrials.gov under registration number NCT02163889.).
引用
- Mylonakis E, Zacharioudakis IM, Clancy CJ, et al. Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial. J Clin Microbiol. 2018. PMID: 29367293. doi:10.1128/JCM.01756-17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。